Flemming Ornskov Archives - CDR

Shire set to release Xiidra dry eye drops in U.S.

July 13, 2016 by Chain Drug Review dry eye, Flemming Ornskov, lifitegrast ophthalmic solution, Shire, Xiidra Leading Headlines, Pharmacy, Supplier News

LEXINGTON, Mass. — Shire plc has received Food and Drug Administration approval for Xiidra 5% (lifitegrast ophthalmic solution), a twice-daily eye drop solution for dry eye. Plans call for Xiidra to launch in the United States in the third quarter. Shire said the product represents the only prescription eye drop indicated for the treatment of

Shire to acquire Baxalta in $32 billion deal

January 11, 2016 by Chain Drug Review Baxalta, Flemming Ornskov, Ludwig Hantson, Shire Business, Leading Headlines, Supplier News

DUBLIN, Ireland, and BANNOCKBURN, Ill. — Shire plc plans to buy Baxalta Inc., a biopharmaceutical company focused on orphan diseases and underserved conditions, in a cash and stock deal valued at $32 billion. Under the agreement, Baxalta shareholders will receive $18 in cash and 0.1482 Shire American depositary shares per Baxalta share, for a combined of